AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析

◆英語タイトル:AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH430057FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:74
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥41,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

AbbVie Inc (ABBV) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AbbVie Inc (AbbVie) is a specialty biopharmaceutical company which discovers, develops, manufactures and commercializes drugs for the treatment of chronic and complex diseases. Its pharmaceuticals are indicated to treat metabolic diseases, rheumatological diseases, neurological disorders, viral diseases, skin diseases, complications associated with cystic fibrosis, pain related to endometriosis, diseases of the gastrointestinal tract, various cancer types, and other serious health conditions. AbbVie is also advancing its pipeline programs for the treatment of cystic fibrosis, Women’s Health, various cancers, neurological disorders and other autoimmune diseases. The company markets its products directly to wholesalers, distributors, health care facilities, government agencies, specialty pharmacies and independent retailers through its own distribution centers and public warehouses across the world. AbbVie is headquartered in North Chicago, Illinois, the US.

AbbVie Inc Key Recent Developments

Feb 23,2021: New REFRESH DIGITAL Lubricant Eye Drops tackle Eye Dryness due to everyday screen use
Feb 19,2021: Feb 19, 2021 AbbVie to Present at the Cowen 41st Annual Health Care Conference
Feb 19,2021: AbbVie, Evolus, and Medytox announce resolution of intellectual property litigation
Feb 18,2021: AbbVie declares quarterly dividend
Feb 12,2021: AbbVie to Present at the 10th Annual SVB Leerink Global Healthcare Conference

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
AbbVie Inc – Key Facts
AbbVie Inc – Key Employees
AbbVie Inc – Key Employee Biographies
AbbVie Inc – Major Products and Services
AbbVie Inc – History
AbbVie Inc – Company Statement
AbbVie Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
AbbVie Inc – Business Description
Product Category: All Other
Performance
Product Category: Creon
Performance
Product Category: Duodopa
Performance
Product Category: Humira
Performance
Product Category: Imbruvica
Performance
Product Category: Lupron
Performance
Product Category: Mavyret
Performance
Product Category: Orilissa/Oriahnn
Performance
Product Category: Rinvoq
Performance
Product Category: Skyrizi
Performance
Product Category: Synthroid
Performance
Product Category: Venclexta
Performance
Product Category: Pharmaceuticals
Overview
Performance
Geographical Segment: All Other Countries
Performance
Geographical Segment: Brazil
Performance
Geographical Segment: Canada
Performance
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Italy
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Spain
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
R&D Overview
AbbVie Inc – Corporate Strategy
AbbVie Inc – SWOT Analysis
SWOT Analysis – Overview
AbbVie Inc – Strengths
AbbVie Inc – Weaknesses
AbbVie Inc – Opportunities
AbbVie Inc – Threats
AbbVie Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AbbVie Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 23, 2021: New REFRESH DIGITAL Lubricant Eye Drops tackle Eye Dryness due to everyday screen use
Feb 19, 2021: Feb 19, 2021 AbbVie to Present at the Cowen 41st Annual Health Care Conference
Feb 19, 2021: AbbVie, Evolus, and Medytox announce resolution of intellectual property litigation
Feb 12, 2021: AbbVie to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 11, 2021: AbbVie and Caribou enter $340m deal to develop CAR-T cell therapies
Feb 03, 2021: AbbVie Reports Full-Year and Fourth-Quarter 2020 Financial Results
Feb 03, 2021: Calico and AbbVie share update on early-stage clinical programs
Jan 21, 2021: ProBioGen licenses GlymaxX technology to AbbVie
Jan 15, 2021: AbbVie to Host Fourth-Quarter and Full-Year 2020 Earnings Conference Call
Dec 09, 2020: AbbVie announces partners in $50 million program to promote health and education equity in underserved black communities
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
AbbVie Inc, Key Facts
AbbVie Inc, Key Employees
AbbVie Inc, Key Employee Biographies
AbbVie Inc, Major Products and Services
AbbVie Inc, History
AbbVie Inc, Subsidiaries
AbbVie Inc, Key Competitors
AbbVie Inc, Ratios based on current share price
AbbVie Inc, Annual Ratios
AbbVie Inc, Annual Ratios (Cont...1)
AbbVie Inc, Annual Ratios (Cont...2)
AbbVie Inc, Interim Ratios
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
AbbVie Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
AbbVie Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[AbbVie Inc (ABBV):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Essar Power Limited:企業の発電所・SWOT分析2018
    Essar Power Limited - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • China Petrochemical Development Corporation (1314):企業の財務・戦略的SWOT分析
    China Petrochemical Development Corporation (1314) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Telenor ASA:企業の戦略・SWOT・財務分析
    Telenor ASA - Strategy, SWOT and Corporate Finance Report Summary Telenor ASA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bank of China Ltd:戦略・SWOT・企業財務分析
    Bank of China Ltd - Strategy, SWOT and Corporate Finance Report Summary Bank of China Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Malayan Flour Mills Berhad:企業の戦略・SWOT・財務分析
    Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report Summary Malayan Flour Mills Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SSP Group Ltd:企業の戦略・SWOT・財務分析
    SSP Group Ltd - Strategy, SWOT and Corporate Finance Report Summary SSP Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • North Eastern Electric Power Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary North Eastern Electric Power Corp Ltd (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and solar sources; …
  • Cegid Group SA (CGD):企業の財務・戦略的SWOT分析
    Cegid Group SA (CGD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Wayne State University:製薬・医療:M&Aディール及び事業提携情報
    Summary Wayne State University (WSU) is a public research university that offers academic and certificate programs for graduates and undergraduates. The university offers academic programs such as business, engineering, information science, arts and sciences, law, medicine, nursing and health scienc …
  • Norsk Hydro ASA (NHY):電力:M&Aディール及び事業提携情報
    Summary Norsk Hydro ASA (Hydro) is a global supplier of aluminum and an electricity producer. Its operations span the value chain, from bauxite extraction to the production of rolled and extruded aluminum products and building systems. Its portfolio of products include bauxite, alumina, extrusion in …
  • Hunt Oil Co:企業の戦略的SWOT分析
    Hunt Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • MILEI GmbH:戦略・SWOT・企業財務分析
    MILEI GmbH - Strategy, SWOT and Corporate Finance Report Summary MILEI GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Zara Investment (Holding) Co Ltd:企業の戦略・SWOT・財務分析
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Opiant Pharmaceuticals Inc (OPNT):企業の財務・戦略的SWOT分析
    Opiant Pharmaceuticals Inc (OPNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • 2020 GeneSystems Inc:医療機器:M&Aディール及び事業提携情報
    Summary 20/20 GeneSystems Inc (20/20 Gene) is a medical diagnostic company. The company discovers, develops, and commercializes proteomics products and diagnostic tests for therapy selection, early disease detection, and biodefense applications. It provides tests in the areas of early detection of l …
  • Jordan Health Services Inc-製薬・医療分野:企業M&A・提携分析
    Summary Jordan Health Services Inc (Jordan) is a healthcare service provider that offers home healthcare services. The center offers personal care services, home management, pediatric services, skilled care and hospice services. It provides pediatric programs which include comprehensive care program …
  • Nabors Industries Ltd.:戦略・SWOT・企業財務分析
    Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nabors Industries Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Samsung Electronics Co Ltd (005930)-医療機器分野:企業M&A・提携分析
    Summary Samsung Electronics Co., Ltd. (Samsung) is a manufacturer of consumer electronics, information technology and mobile communications, and device solutions. The company’s product portfolio includes television (TV), washing machine, refrigerator, air conditioner, medical devices, monitor, print …
  • Jiangsu Expressway Co Ltd (600377):企業の財務・戦略的SWOT分析
    Summary Jiangsu Expressway Co Ltd (Jiangsu Expressway) is a highway development company that offers services in investment, construction, operation and management of toll expressways within Jiangsu province. The company offers services such as geographical services, service area development, express …
  • Epiroc AB (EPI A):企業の財務・戦略的SWOT分析
    Epiroc AB (EPI A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆